Clinical Trial: Evaluate the Efficacy and Safety of GZR33 Injection in Patients With Type 2 Diabetes

U.S., April 15 -- ClinicalTrials.gov registry received information related to the study (NCT07527078) titled 'Evaluate the Efficacy and Safety of GZR33 Injection in Patients With Type 2 Diabetes' on April 08.

Brief Summary: Evaluate the efficacy of GZR33 Injection and Insulin Degludec Injection (Tresiba(R)) in Patients with Type 2 Diabetes Mellitus Inadequately Controlled with Oral Antidiabetic Drugs.

Study Start Date: April 07

Study Type: INTERVENTIONAL

Condition: Type 2 Diabetes (T2DM)

Intervention: DRUG: GZR33 Injection

GZR33 Injection Administered SC, once-daily

DRUG: Insulin Degludec Injection (Tresiba(R))

Administered SC, once-daily

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Gan & Lee Pharmaceuticals.

Disclaimer: Cur...